# The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies

> **NCT01393509** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 47 (actual)

## Conditions studied

- Metastatic Solid Tumor
- Lymphoma
- Myeloproliferative Neoplasms (MPN)

## Interventions

- **DRUG:** PU-H71

## Key facts

- **NCT ID:** NCT01393509
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-06
- **Primary completion:** 2023-03-23
- **Final completion:** 2023-03-23
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01393509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01393509, "The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01393509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*